In AD, for instance, cerebrospinal fluid levels of irisin correlate with AD biomarkers and clinical dementia scores [233,234], and animal models show that higher irisin levels are associated with reduced amyloid pathology and improved memory [94,205,235]. This evidence concerns the gene FNDC5 and dementia.